Fetal Cystoscopy for Severe Lower Urinary Tract Obstruction

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorRodrigo Ruano

About this trial

The purpose of the study is to study the outcomes of maternal and fetal patients who are undergoing fetal intervention for severe isolated lower urinary tract obstruction (LUTO).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Pregnant women

Singleton pregnancy

Maternal age ≥ 18 years

Male fetus with LUTO, dilated bladder, "keyhole sign" and bilateral hydronephrosis

Disqualifiers

Fetal anomaly unrelated to LUTO

Congenital cardiac anomaly

Female fetus

Increased risk for preterm labor including short cervical length (<1.5 cm), history of incompetent cervix with or without cerclage, and previous preterm birth

Trial design

Design model

Single group

Treatments tested in this trial

  • Fetoscopes

    Device

    Fetoscopes are telescopes developed for procedures involving fetal interventions and is inserted through the maternal abdomen.

  • Fetal Cystoscopy

    Procedure/Surgery

    A fetoscope will be inserted into the fetal bladder via the maternal abdomen and advanced into the fetal bladder outlet. Identified obstruction will be opened using laser.

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: Fetal Cystoscopy GroupExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Number of participants where the procedure was technically performed

Number of participants where the fetal cystoscopy procedure was successfully technically performed.

Time frame
Day 1 (Post fetal cystoscopy procedure)
2

Number of participants where the etiology of LUTO was correctly diagnosed

Number of participants where the etiology of LUTO was correctly diagnosed during fetal cystoscopy as compared to post natal cystoscopy

Time frame
Up to 1 month post delivery
3

Number of participants where the posterior urethral valve were successfully released

Number of participants where the posterior urethral valve were successfully released

Time frame
Day 1 (Post fetal cystoscopy procedure)
4

Number of participants whose fetal cystoscopy resulted in the prevention of post-natal severe pulmonary hypoplasia

As per treating physician evaluation of clinical assessments post-natal.

Time frame
Up to 1 month post delivery

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Rodrigo Ruano

Lead sponsor

University of Miami

Sponsor institution